Develop and manufacture biotherapeutics that address significant medical needs.
Public Law 111-152, the Health Care and Education Reconciliation Act of 2010 - taxes and fees assessed on the pharmaceutical industry. Public Law 111-148, the Patient Protection and Affordable Care Act - Medicare and Medicaid reimbursement for biotherapeutics, comparative effectiveness research, and legislative/regulatory issues involved in FDA approval of follow-on biologics.
Public Law 111-152, the Health Care and Education Reconciliation Act of 2010 - Medicare and Medicaid reimbursement for biotherapeutics, payments under the 340B program, fees on pharmaceutical companies, the Medicare prescription drug benefit. Public Law 111-148, the Patient Protection and Affordable Care Act  - Medicare and Medicaid reimbursement for biotherapeutics. H.R. 1548, the Pathway for Biosimilars Act, FDA approval of follow-on biologics.
H.R. 1427 and S. 726, the Promoting Innovation and Access to Life-Saving Medicine Act, FDA approval of follow-on biologics.
Public Law 111-148, the Patient Protection and Affordable Care Act - FDA approval of follow-on biologics and length of data exclusivity period, 340B drug pricing program, design and structure of the Medicare prescription drug benefit. Public Law 111-152, the Health Care and Education Reconciliation Act of 2010 - Medicare and Medicaid reimbursement issues, fees assessed on the pharmaceutical industry, design and structure of the Medicare prescription drug benefit.
S. 1232, the Pharmaceutical Market Access and Drug Safety Act, importation of prescription drugs. Public Law 111-148, the Patient Protection and Affordable Care Act of 2009 - authorization for comparative effectiveness research.
S. 1213, the Patient-Centered Outcomes Research Act of 2009 - authorization for comparative effectiveness research.
TAX - Taxation/Internal Revenue Code HCR - Health Issues MMM - Medicare/Medicaid PHA - Pharmacy MED - Medical/Disease Research/Clinical Labs
11 - Executive Office of the President (EOP) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 11 - Executive Office of the President (EOP) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 11 - Executive Office of the President (EOP) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 11 - Executive Office of the President (EOP) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 11 - Executive Office of the President (EOP) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
TARPLIN STRATEGIES LLC
975 F Street NW Suite 500, Washington, DC, 20004, US
RICHARD JOSEPH TARPLIN (and Families) RICHARD JOSEPH TARPLIN (and Families) RICHARD JOSEPH TARPLIN (and Families) RICHARD JOSEPH TARPLIN (and Families) RICHARD JOSEPH TARPLIN (and Families)
and Families and Families and Families and Families and Families